FDA grants Emergency Use Authorization for Regeneron’s antibody treatment
November 23, 2020Sales and Marketing
The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …
Johnson & Johnson set to pay $120 million in New York baby powder case
November 23, 2020Sales and Marketing
A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …
World Health Organization does not recommend using remdesivir to treat COVID-19
November 20, 2020Medical Communications
The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how …
Eli Lilly and Ypsome partner to advance automated insulin delivery system
November 20, 2020Medical Communications
Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …
Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today
November 20, 2020Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
First recombinant influenza vaccine approved in the European Union
November 20, 2020Medical Communications, Sales and Marketing Europe, influenza, pharma
The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
Top Ten most popular articles on Pharmafile.com this week
November 20, 2020Medical Communications
The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …
Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1
November 19, 2020Research and Development Gilead, HIV, pharma
Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …
OPEN Health reveals new CEO appointment
November 19, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health
Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
First multiple sclerosis clinical trial for patients who can’t walk to begin recruitment
November 19, 2020Business Services
The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year. …
Five Chinese coronavirus vaccines in overseas clinical trials
November 19, 2020Business Services
Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world. The countries conducting the …
Vietnam selected as Asian pilot country for UK’s new global healthcare partnership
November 19, 2020Business Services
A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has …
Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia
November 18, 2020Research and Development
Bristol Myers Squibb has announced that its acquisition of MyoKardia has been completed, with the transaction worth a total of …
NICE recommends Lilly’s Emgality for chronic and episodic migraine
November 18, 2020Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK
Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
FDA approves first at-home coronavirus self-testing kit
November 18, 2020Research and Development
The FDA has issued an Emergency Use Authorization for the first coronavirus self-testing kit for use at home that produces …
Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s
November 18, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
Pharmafile.com’s weekly COVID-19 news round-up
November 18, 2020Research and Development
The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created …
AstraZeneca’s Brilinta reduces stroke and death risk in head and neck artery atherosclerosis patients
November 17, 2020Manufacturing and Production
AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had …
Pfizer takes legal action against Indian drugmakers over generic cancer drug
November 17, 2020Manufacturing and Production
Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges …
Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn
November 17, 2020Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
